Position in GLAS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$52
New position
Shares Held
4
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#53
of 53 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FMR LLC holds $7,214,215,829 across 49 Drug Manufacturers - Specialty & Generic names. GLAS ranks #46 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
96,662,102 | $1,534,994,177 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
56,948,819 | $1,401,510,433 | |
| 3 | HLN |
Haleon plc
|
120,991,250 | $1,128,848,360 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
30,258,016 | $1,025,141,579 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
6,971,361 | $445,818,534 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
3,879,971 | $430,443,982 | |
| 7 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
16,727,909 | $300,433,243 | |
| 8 | UTHR |
UNITED THERAPEUTICS Corp
|
473,409 | $256,507,196 |
All Filings in GLAS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $52 | 4 | Shares | Defined | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||